HomeLBank Stocks
Beta Bionics, Inc. Common Stock
Beta Bionics, Inc. Common Stock

Beta Bionics, Inc. Common Stock (BBNX)

24HHigh$22.2224HLow$18.40
$22.21
+0.19%

Last updated: 2026-09-17 10:10:38

K-Line Chart, actual market data is subject to the trading page.

Key Data

Prev. Open
$18.61
Prev. Close
$22.21
Prev. Day's Range
$18.40 - $22.22
52W Range
$8.80 - $32.71
Trading Volume
6.071M
MC
$865.152M
P/E Ratio
--
EPS
$-1.84

Company Overview

NASDAQ

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company is headquartered in Irvine, California.

SectorHEALTHCARE
IndustryMEDICAL DEVICES
Headquarters11 HUGHES, IRVINE, CA, UNITED STATES, 92618
CountryUSA
Listing Date2025-01-30
Fiscal Year Ended2026-06-30
Shares Outstanding44.99M
CIK Code1674632

Financial Metrics

Indicator2026-03-312025-12-312025-09-302025-06-30
Income$27.626M$32.121M$27.253M$23.238M
Operating Expenses$11.189M$13.177M$12.134M$10.735M
Net Income-$21.895M-$13.466M-$14.209M-$16.869M
Net Profit Margin-79.3%-41.9%-52.1%-72.6%
Earnings Per Share--------
EBITDA-$21.224M-$12.53M-$13.526M-$16.216M
Effective Tax Rate---0.0%----

FAQ

BBNX operates in the [sector] sector, within the [industry] industry. The company's core business involves [key activities], with a focus on [main products/services]. It generates revenue primarily through [main revenue drivers], making it an important entity in its market space.
BBNX is part of the [sector] sector, specifically within the [industry] industry. Its operations are aligned with trends and demands in this business landscape, highlighting its role in [sector-specific activities].
Investing in BBNX presents opportunities such as [specific opportunities, if known]. However, it also carries risks, including market volatility, competition within the [industry], and potential shifts in [relevant external factors]. Investors should evaluate these elements when considering the stock.
At present, BBNX [does/does not] offer dividends to its shareholders. This decision reflects its financial strategy and allocation priorities, which may focus on [growth, reinvestment, etc.]. Investors seeking income from dividends should factor this into their evaluation.
BBNX competes with several companies within the [industry] industry. Key competitors include [competitor names, if known]. Its ability to differentiate through [specific advantage] is a critical aspect of its performance in the competitive market.
BBNX primarily generates revenue through [main revenue streams]. These include [specific methods, if applicable]. Its business model is designed to capitalize on [industry-specific trends], which drives profitability.
Investors considering BBNX should examine elements such as its earnings reports, valuation metrics, and price trends compared to industry benchmarks. Other key factors include its growth potential, market share, and any financial risks it faces.
External factors such as regulatory changes, market demand, and macroeconomic conditions significantly influence BBNX's performance. The company's adaptability to such influences is key to maintaining its competitive edge.
Risk Warning
  1. 1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
  2. 2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
  3. 3.The information contained on this page is for reference only and does not constitute any investment advice.